XML 23 R13.htm IDEA: XBRL DOCUMENT
v3.22.2

Goodwill and Intangible Assets | 6 Months Ended
--- | ---
Jun. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract] |
Goodwill and Intangible Assets | Goodwill and Intangible Assets Goodwill Goodwill arises from the acquisition method of accounting for business combinations and represents the excess of the purchase price over the fair value of the net assets and other identifiable intangible assets acquired. The fair values of net tangible assets and intangible assets acquired are based upon preliminary valuations and the Company’s estimates and assumptions are subject to change within the measurement period (potentially up to one year from the acquisition date). During the six months ended June 30, 2022, there was an increase in the carrying value of goodwill of $0.07 million related to minor adjustments to assets and liabilities in the purchase price allocation for Company X. The Company performs an annual goodwill impairment assessment on October 31st each year, using a quantitative assessment comparing the fair value of each reporting unit, which the Company has determined to be the entity itself, with its carrying amount, including goodwill. If the carrying amount of a reporting unit exceeds its fair value, an impairment loss is recorded. In addition to its annual review, the Company performs a test of impairment when indicators of impairment are present. During the three and six months ended June 30, 2022 and 2021, there were no indications of impairment of the Company’s goodwill balances. Acquired Intangibles Finite-lived Intangible Assets The following table sets forth the Company’s finite-lived intangible assets resulting from business acquisitions and other purchases, which are amortized over their estimated useful lives:
|  |  | June 30, 2022 |  | December 31, 2021
| Weighted Average Useful Life (in Years) |  | Gross Carrying Amount |  | Accumulated Amortization |  | Net Carrying Amount |  | Gross Carrying Value |  | Accumulated Amortization |  | Net Carrying Amount
|  |  | (in thousands)
Licensed technology | 6.3 |  | $ | 22,054 |  |  | $ | (3,034) |  |  | $ | 19,020 |  |  | $ | 16,850 |  |  | $ | (2,218) |  |  | $ | 14,632 |
Developed technology | 7.0 |  | 311,261 |  |  | (209,876) |  |  | 101,385 |  |  | 308,661 |  |  | (189,244) |  |  | 119,417 |
Trademarks and trade names | 6.2 |  | 14,800 |  |  | (12,381) |  |  | 2,419 |  |  | 14,800 |  |  | (11,221) |  |  | 3,579 |
Customer relationships | 5.0 |  | 128,800 |  |  | (124,037) |  |  | 4,763 |  |  | 128,800 |  |  | (116,847) |  |  | 11,953 |
Backlog | 2.4 |  | 1,300 |  |  | (959) |  |  | 341 |  |  | 1,300 |  |  | (941) |  |  | 359 |
| 6.2 |  | $ | 478,215 |  |  | $ | (350,287) |  |  | $ | 127,928 |  |  | $ | 470,411 |  |  | $ | (320,471) |  |  | $ | 149,940 |
The following table sets forth amortization expense associated with finite-lived intangible assets, which is included in the consolidated statements of income as follows:
| Three Months Ended June 30, |  | Six Months Ended June 30, |  |
| 2022 |  | 2021 |  | 2022 |  | 2021 |  |
| (in thousands) |  | (in thousands)
Cost of net revenue | $ | 9,865 |  |  | $ | 10,762 |  |  | $ | 20,712 |  |  | $ | 21,527 |  |  |
Research and development | 1 |  |  | 1 |  |  | 2 |  |  | 2 |  |  |
Selling, general and administrative | 2,926 |  |  | 5,815 |  |  | 9,102 |  |  | 11,885 |  |  |
| $ | 12,792 |  |  | $ | 16,578 |  |  | $ | 29,816 |  |  | $ | 33,414 |  |  |
Amortization of finite-lived intangible assets in cost of net revenue in the consolidated statements of income results primarily from acquired developed technology. The following table sets forth the activity related to finite-lived intangible assets:
| Six Months Ended June 30,
| 2022 |  | 2021
| (in thousands)
Beginning balance | $ | 149,940 |  |  | $ | 200,066 |
Additions | 5,204 |  |  | 1,112 |
Transfers to developed technology from IPR&D | 2,600 |  |  | — |
Amortization | (29,816) |  |  | (33,414) |
Ending balance | $ | 127,928 |  |  | $ | 167,764 |
The Company regularly reviews the carrying amount of its long-lived assets subject to depreciation and amortization, as well as the related useful lives, to determine whether indicators of impairment may exist that warrant adjustments to carrying values or estimated useful lives. An impairment loss is recognized when the sum of the expected future undiscounted net cash flows is less than the carrying amount of the asset. Should impairment exist, the impairment loss is measured based on the excess of the carrying amount of the asset over the asset’s fair value. During each of the three and six months ended June 30, 2022 and 2021, no impairment losses related to finite-lived intangible assets were recognized. The following table presents future amortization of the Company’s finite-lived intangible assets at June 30, 2022:
| Amount
| (in thousands)
2022 (6 months) | $ | 21,956 |
2023 | 40,315 |
2024 | 25,107 |
2025 | 13,772 |
2026 | 12,661 |
Thereafter | 14,117 |
Total | $ | 127,928 |
Indefinite-lived Intangible Assets Indefinite-lived intangible assets consist entirely of acquired in-process research and development technology, or IPR&D. The following table sets forth the Company's activities related to indefinite-lived intangible assets:
| Six Months Ended June 30,
| 2022 |  | 2021
| (in thousands)
Beginning balance | $ | 2,600 |  |  | $ | 2,600 |
Transfers to developed technology from IPR&D | (2,600) |  |  | — |
Ending balance | $ | — |  |  | $ | 2,600 |
The Company performs its annual assessment of indefinite-lived intangible assets on October 31 each year or more frequently if events or changes in circumstances indicate that the asset might be impaired utilizing a qualitative test as a precursor to the quantitative test comparing the fair value of the assets with their carrying amount. Based on the qualitative test, if it is more likely than not that indicators of impairment exists, the Company proceeds to perform a quantitative analysis. During the three and six months ended June 30, 2022 and 2021, no indicators of impairment were identified and, as a result, no IPR&D impairment losses were recorded.

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for goodwill and intangible assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -URI https://asc.fasb.org/topic&trid=2144416 + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration